Global Hyaluronidase Market, Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Hyaluronidase Market” report produced by MarketResearch.biz which is segmented on the basis of type, application, and region. Various secondary and primary research was conducted to come across findings and conclusions, which are provided in the report. In addition, various aspects and information regarding key players in the global market, key drivers, trends, restraints, market growth opportunities, present and future revenue possibilities, etc. are discussed in the report in detail. In the report, various aspects such as Y-o-Y growth, growth factors, major trends, future forecast & opportunities, restraints are included in detail. Moreover, various possibilities and opportunities for generation of potential revenue are also highlighted in the report. Key player profiles discusses various elements such as developments by companies, company details, acquisitions, effective strategies, developments, and mergers.
Hyaluronidases, a type of enzyme, are used to catalyze degrading of hyaluronic acid. The known German biochemist Karl Meyer, classified these enzymes into three distinct groups in 1971. In order to treat dehydration, Hyaluronidase is used along with fluids as injections. It is also used to help body to absorb various other medications, which are injected to body. Hyaluronidase can also assist contrast dyes in body to show with increased clarity on certain kinds of scans or X-rays. Hyaluronidases, which are class of enzymes, are also present in different venoms and toxins. Although hyaluronidases have various advantages, it also has got many side effects such as injection site reactions such as pain, redness, itching, redness, swelling, or tenderness, swelling parts of body and various allergic reactions such as hives.
The major factor driving growth of the global hyaluronidase market increasing penetration across different application areas and presence of various clinical studies for demonstrating efficacy of the product. Hyaluronidase has applications in cancer therapy, cosmetic treatments, and therapeutic solutions. Its growing role in cancer therapy and treatment is expected to further drive growth of the global hyaluronidase market over the forecast period. In addition, increasing awareness about alteration of various physical appearance has been increasing demand for aesthetics and cosmetics product procedures. Increasing prevalence of skin disorders and easy access to various advanced cosmetic treatments are expected to drive growth of the market over the forecast period. Other factors projected further drive growth of the global market are growing geriatric population, good reimbursement policies, and an increasing number of consumers opting for nonsurgical procedures. Technological advancements in healthcare are also expected to be a major factor driving demand for the product in the global hyaluronidase market. Medicines made out of hyaluronidase are easily available in hospitals and medical stores, which is expected to further drive growth of the market over the forecast period. However, various side effects of the product on human body is projected hamper growth of the market over the forecast period.
Global Hyaluronidase Market Segment Analysis:
By Type: Among the type segments, the animal-derived hyaluronidase segment is projected to account for the majority revenue share in the market and is expected to continue over the forecast period. This growth of the segment is attributed to wide popularity approved and commercial brands, which are from an animal source.
By Application: The dermatology segment has been gaining traction. This increase of the segment is attributed to growing uses of hyaluronidase in dermatology. In addition, growing number of consumers with various skin diseases and disorders is attributed to the growth of the segment.
Global Hyaluronidase Market Regional Analysis:
The market in North America is projected to dominate the market in terms of revenue share over the forecast period. This can be attributed to increasing adoption of the product for various t treatments, presence of key players in the region, an increasing number of dermatology clinics in the region and prescribing such treatments. Asia pacific is the fastest growing market, owing to increasing number of people with various skin diseases and disorders.
Global Hyaluronidase Market Segmentation:
- Animal-derived Hyaluronidase
- Synthetic Hyaluronidase
- Plastic Surgery
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Amphastar Pharmaceuticals, Inc.
- PrimaPharma, Inc.
- Halozyme, Inc.
- Bausch & Lomb Incorporated
- The Cooper Companies Inc.
- Sun Pharmaceutical Industries Ltd.
- STEMCELL Technologies Inc.
- Shreya Life Sciences Pvt. Ltd.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!